Skip to main content
    H

    Hims Hers Health Inc (HIMS)

    Official site

    HEALTHCARE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE

    $18.55
    -1.18 (-5.98%)

    Market Cap: $4.62B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Hims Hers Health Inc (HIMS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Hims Hers Health are Lantheus Holdings (LNTH), HUTCHMED DRC (HCM) and Prestige Brand Holdings (PBH). By market cap, Hims Hers Health ranks 4th of the 13 companies on this page; Kiniksa Pharmaceuticals (KNSA) is the largest at $7.57B. The median P/E of the 10 companies with a P/E is 14.3x.

    Peer Comparison

    HIMS's ROIC of -11.1% is below the peer median of 11.6%, and its revenue growth of 48.6% is above the median of 11.7%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Hims Hers Health (HIMS)$4.62BN/A1.5x-6.7%-11.1%48.6%0.00%
    Lantheus Holdings Inc (LNTH)$6.64B17.9x4.5x17.3%14.8%1.5%0.00%
    HUTCHMED DRC (HCM)$2.59BN/A4.7x3.3%-2.4%0.2%0.00%
    Prestige Brand Holdings Inc (PBH)$2.19B10.7x2.0x13.3%5.0%22.7%0.00%
    Bausch Health Companies Inc (BHC)$3.13B1.7x0.3x-7.6%6.3%9.7%0.00%
    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)$7.45B21.4x2.2x4.2%11.6%10.0%0.00%
    Xeris Pharmaceuticals Inc (XERS)$3.04B139.2x8.2x-1.8%15.5%44.2%0.00%
    Harrow Health Inc (HROW)$1.13BN/A3.6x-9.4%-0.3%38.6%0.00%
    Indivior PLC Ordinary Shares (INDV)$4.28B6.6x2.4x32.8%109.0%13.4%0.00%
    Kiniksa Pharmaceuticals Ltd (KNSA)$7.57B72.5x7.8x11.6%N/A58.1%0.00%
    Phibro Animal Health Corporation (PAHC)$1.46B10.7x0.9x6.7%11.7%6.3%1.37%
    Eton Pharmaceuticals Inc (ETON)$1.84B36.7x13.0x35.3%37.0%157.9%0.00%
    Perrigo Company PLC (PRGO)$2.25B7.0x0.6x-43.3%-26.3%-5.2%7.17%
    Peer median$2.82B14.3x3.0x5.4%11.6%11.7%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Hims Hers Health, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.

    CompanyAboutPeers
    Lantheus Holdings Inc (LNTH)
    Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment...
    LNTH competitors
    HUTCHMED DRC (HCM)
    HUTCHMED (China) Limited discovers, develops and markets targeted immunotherapies and therapies for cancer and immune diseases globally.
    Prestige Brand Holdings Inc (PBH)
    Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States...
    PBH competitors
    Bausch Health Companies Inc (BHC)
    Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical...
    BHC competitors
    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)
    Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms...
    AMRX competitors
    Xeris Pharmaceuticals Inc (XERS)
    Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations.
    XERS competitors
    Harrow Health Inc (HROW)
    Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California.
    HROW competitors
    Indivior PLC Ordinary Shares (INDV)
    Indivior PLC, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence...
    Kiniksa Pharmaceuticals Ltd (KNSA)
    Kiniksa Pharmaceuticals Ltd. (KNSA) is an innovative biopharmaceutical company focused on developing breakthrough therapies to address pressing unmet medical...
    KNSA competitors
    Phibro Animal Health Corporation (PAHC)
    Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily...
    PAHC competitors
    Eton Pharmaceuticals Inc (ETON)
    Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases.
    ETON competitors
    Perrigo Company PLC (PRGO)
    Perrigo Company plc is an American Irish registered manufacturer of private label over-the-counter pharmaceuticals.
    PRGO competitors

    Frequently Asked Questions About HIMS

    Who are Hims Hers Health's main competitors?

    The companies most similar to Hims Hers Health include Lantheus Holdings (LNTH), HUTCHMED DRC (HCM), Prestige Brand Holdings (PBH), Bausch Health Companies (BHC) and Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), listed from the closest match.

    Who is Hims Hers Health's biggest competitor?

    Kiniksa Pharmaceuticals (KNSA) is the largest of the similar companies at $7.57B; Lantheus Holdings (LNTH) is the closest match by business profile, size, sector and industry.

    How does HIMS stock compare with its competitors?

    HIMS' P/S is 1.5x against a peer median of 3.0x; its net margin is -6.7% against a peer median of 5.4%.

    Which of Hims Hers Health's competitors pays a higher dividend?

    Hims Hers Health pays no dividend. Perrigo Company (PRGO) and Phibro Animal Health (PAHC) have higher forward dividend yields; Perrigo Company (PRGO) has the highest at 7.17%.

    Is Hims Hers Health bigger than its competitors?

    No. Hims Hers Health is 4th by market cap among the 13 companies on this page; the largest is Kiniksa Pharmaceuticals (KNSA) at $7.57B.